Information technology giant Hewlett Packard Enterprise (NYSE: HPE) is scheduled to report second-quarter 2019 financial results on Thursday, May 23, after the closing bell. Analysts expect the company to report Q2 earnings of 36 cents per share, on revenues of $7.44 billion, down 0.4% year-over-year.
The Wall Street earnings estimate falls within the management projection for the quarter of 34 to 38 cents per share. It may be noted that the company has surpassed analysts’ estimate in the past four quarters.
In the last-reported quarter, HPE’s earnings more-than-doubled to $0.34 per share, aided by broad-based demand growth that lifted revenues by 10% to $7.5 billion. Buoyed by the strong results, the management revised up its outlook for the fiscal year.
While Aruba products and services are expected to drive growth in the Intelligent Edge unit, Nimble is likely to push storage revenues. However, the residual impact from the exit of the Tier-1 server business may offset much of the growth in the other units.
Hewlett Packard has also been on a mission to diversify its portfolio. The most recent move in this regard is the acquisition of Cray (NASDAQ: CRAY) for about $1.30 billion, which gives HPE a leeway into the supercomputer business.
The deal values Cray’s stock at $35, representing a premium
of about 17%, and is tentatively scheduled to close early next year. It is
expected to be accretive to HPE’s adjusted earnings after one full year of
completion. Meanwhile, the management has left its free cash flow outlook
for fiscal 2020 unchanged at $1.9-$2.1 billion, after
factoring in the integration costs associated with the transaction.
The acquisition is meaningful in a way that it helps HPE stay relevant in a competitive market that is dominated by the likes of International Business Machines (NYSE: IBM).
HPE shares have gained 13.4% in the year-to-date period. The stock has a 12-month average price target of $16.56, suggesting an 8% upside from the current trading price. Most analysts covering the stock have a Hold rating.
Listen to on-demand earnings calls and hear how management responds to analysts’ questions
Most Popular
Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO
Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training
INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues
Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came
Riding the AI wave, Nvidia looks set to stay on the high-growth path
After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on